On Tuesday, Shares of ArcelorMittal SA (ADR)(NYSE:MT), included 8.36% and shut at $7.65 inside the end purchasing and offering session. The last exchanging scope of the stock ranges amongst $7.41 and $7.69. ArcelorMittal, Evonik, LafargeHolcim and Solvay recently declare the formation of a new Low Carbon Technology Partnerships Program across the steel, cement and chemicals industries.
This new partnership will look at the potential synergies that exist between the manufacturing processes of these three energy intensive sectors, and how these synergies could be harnessed to reducing CO2 emissions.
As a first step, and following preliminary research, the innovative partnership will produce a study (**) with the technical support of Arthur D. Little to identify potential ways to valorise industrial off-gases and other by-products from their manufacturing processes to produce goods with a lower carbon footprint than through the fossil path. The preliminary research already allowed identifying noteworthypotential in selected trans-sector pathways.
Shares of Skyline Medical Inc (NASDAQ:SKLN), added 127.88% and shut at $7.74 inside the last exchanging session. The rest of the purchasing and offering scope of the stock levels among $2.96 and $6.05. The association’s commercial center capitalization is $18.66 million with the general uncommon loads of 3.80 million. Skyline Medical Inc. (SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, declares that it has received a Medical Device Establishment License to sell the STREAMWAY System and related disposables in Canada.
A number of distributors have expressed interest in selling STREAMWAY into Canada’s healthcare system. Skyline has now begun talks with several of them and anticipates within the next few weeks to come to terms with one or more distributors, covering about 1,500 hospitals in all 13 provinces of Canada.
“We look forward to bringing the STREAMWAY System and its many benefits to healthcare professionals and facilities to the about 10,000 operating rooms across Canada,” said Dr. Carl Schwartz, executive chairman of Skyline Medical. “This approval follows receipt of ISO 13485:2003 certification for the STREAMWAY System, which not only was a requirement for Canadian approval, but is necessary for the CE Mark and subsequent sales in the European Union. We are happy to reach this important milestone in our plans for broader distribution of the STREAMWAY System.”